您现在位置：健康网-医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告

Rifampicin Bulk Drug Report

健康网讯：

Market Research Report on Chinese Bulk Rifampicin

Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published:  July 2006 
Format:  Hardcopy and Adobe PDF 
Price:  US$1,500 
Contact: Mr. Bian chenghua   Ms. Wu huifang
Tel.: 86-10-68012929-2116/2101             Fax:  86-10-68012929-2008
E-mail: bianch@healthoo.com   wuhf@healthoo.com                      
http://www.healthoo.com

Directory
1. Overview
    1.1 Definition of Erythromycin Thiocyanate
    1.2 Antimicrobic mechanism
    1.3 Backgroud of Research & Development
    1.4 Mainly uses
2. Domestic production status
    2.1 Overview of production
    2.2 Output,export volume,enterprise share
    2.3 production status of Rifamycin-S sodium
3. Key enterprises
    3.1 Tonglian Group Shenyang Antibiotic Factory
    3.2 Hubei XinGang Biochemical Company
    3.3 Luohe Nanjiecun Pharmaceutical Group
    3.4 Zhengzhou Minzhong Pharmaceutical Co., Ltd
    3.5 Others
4. Proposed projects and projects under construction
5. Price trend
6. Export analysis
    6.1 General status of export
    6.2 Export Destination (Countries or Regions) and market feature
    6.3 Export volume and value structure of main enterprises 
7. Brief remark